Literature DB >> 1057174

Subversion of immune system by tumor cells and role of prostaglandins.

O J Plescia, A H Smith, K Grinwich.   

Abstract

Mice bearing syngeneic tumors, chemical and virus-induced, became immunologically unresponsive to sheep erythrocytes. The increase in the degree of unresponsiveness with tumor growth suggested a causal relationship. Immunosuppression was in fact caused by the tumor cells because the addition of tumor cells to in vitro cultures of spleen cells and sheep erythrocytes resulted in suppression of antibody response. Suppression was dose dependent with a ratio of 1 to 1000 of tumor cells to spleen cells sufficient to produce significant suppression. Prostaglandins were found to have a role in immunosuppression by tumor cells in that PGE2 was itself immunosuppressive and in that indomethacin and aspirin, inhibitors of prostaglandin synthetases, blocked immunosuppression in vitro and retarded tumor growth in vivo. These findings suggest that tumors, although antigenic, may be able to escape immuno-sureillance by their host by means of subverting the immune system. Thus, success of immunotherapy may well depend on our ability to prevent or block the immunosuppressive activity of tumors.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1057174      PMCID: PMC432644          DOI: 10.1073/pnas.72.5.1848

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  8 in total

1.  Immunosuppressive and immunostimulatory factors produced by malignant cells in vitro.

Authors:  A Wong; R Mankovitz; J C Kennedy
Journal:  Int J Cancer       Date:  1974-04-15       Impact factor: 7.396

2.  Immune responses in vitro. I. Culture conditions for antibody synthesis.

Authors:  R E Click; L Benck; B J Alter
Journal:  Cell Immunol       Date:  1972-02       Impact factor: 4.868

3.  Prostaglandins and cyclic nucleotides in Moloney sarcoma tumors.

Authors:  J L Humes; H R Strausser
Journal:  Prostaglandins       Date:  1974-01-25

Review 4.  Immunodeficiency and cancer.

Authors:  J H Kersey; B D Spector; R A Good
Journal:  Adv Cancer Res       Date:  1973       Impact factor: 6.242

5.  Hemolytic plaque formation by leukocytes in vitro. Control by vasoactive hormones.

Authors:  K L Melmon; H R Bourne; Y Weinstein; G M Shearer; J Kram; S Bauminger
Journal:  J Clin Invest       Date:  1974-01       Impact factor: 14.808

6.  Antiinflammatory effects of murine malignant cells.

Authors:  R M Fauve; B Hevin; H Jacob; J A Gaillard; F Jacob
Journal:  Proc Natl Acad Sci U S A       Date:  1974-10       Impact factor: 11.205

7.  Immunization of dissociated spleen cell cultures from normal mice.

Authors:  R I Mishell; R W Dutton
Journal:  J Exp Med       Date:  1967-09-01       Impact factor: 14.307

8.  Evidence that the bone resorption-stimulating factor produced by mouse fibrosarcoma cells is prostaglandin E 2 . A new model for the hypercalcemia of cancer.

Authors:  A H Tashjian; E F Voelkel; L Levine; P Goldhaber
Journal:  J Exp Med       Date:  1972-12-01       Impact factor: 14.307

  8 in total
  51 in total

1.  Inhibition of tumor metastasis by carrageenan-induced granulomas.

Authors:  W J Kort; A M Bijma; I M Hekking
Journal:  Clin Exp Metastasis       Date:  1989 Jan-Feb       Impact factor: 5.150

2.  Studies on inflammatory response induced by Ehrlich tumor in mice peritoneal cavity.

Authors:  D Fecchio; P Sirois; M Russo; S Jancar
Journal:  Inflammation       Date:  1990-02       Impact factor: 4.092

Review 3.  Mononuclear phagocytes and eicosanoids: aspects of their synthesis and biological activities.

Authors:  U F Schade; I Burmeister; E Elekes; R Engel; D T Wolter
Journal:  Blut       Date:  1989-12

4.  Regulation of human immunoglobulin production in vitro by prostaglandin E2.

Authors:  N D Staite; G S Panayi
Journal:  Clin Exp Immunol       Date:  1982-07       Impact factor: 4.330

5.  Influence of zymosan (a non-specific macrophage stimulator) and of indomethacin on liver tumours--an experimental study in rats.

Authors:  S B Holmberg; P L Naredi; G O Lindnér; I H Karlberg; P L Daneryd; L M Karlsson; A Pettersson; U Stenram; L R Hafström
Journal:  J Cancer Res Clin Oncol       Date:  1995       Impact factor: 4.553

6.  Effect of aspirin on mitochondrial mutagens in Saccharomyces cerevisiae.

Authors:  I J Bruce; D Wilkie
Journal:  Mol Gen Genet       Date:  1984

7.  Enhancement of lymphocyte blastogenic and delayed hypersensitivity skin responses by indomethacin.

Authors:  C C Muscoplat; P M Rakich; C O Thoen; D W Johnson
Journal:  Infect Immun       Date:  1978-06       Impact factor: 3.441

8.  Phase II study of celecoxib and docetaxel in non-small cell lung cancer (NSCLC) patients with progression after platinum-based therapy.

Authors:  Bryan J Schneider; Gregory P Kalemkerian; Michael J Kraut; Antoinette J Wozniak; Francis P Worden; Daryn W Smith; Wei Chen; Shirish M Gadgeel
Journal:  J Thorac Oncol       Date:  2008-12       Impact factor: 15.609

9.  Inhibition of tumor growth and metastasis by chronic intravenous infusion of prostaglandin E1.

Authors:  L M Ellis; E M Copeland; K I Bland; H S Sitren
Journal:  Ann Surg       Date:  1990-07       Impact factor: 12.969

Review 10.  Regulation of the immune response by prostaglandins.

Authors:  J S Goodwin; J Ceuppens
Journal:  J Clin Immunol       Date:  1983-10       Impact factor: 8.317

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.